REQUEST FOR INFORMATION: Filters for radiopharmaceutical production and drug manufacturing, as well as for pharmaceuticals and toxic alcohols
About This Opportunity
This is a supplies contract in the health and medical services and trade and industry sectors. Located in Finland, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before November 27, 2026.
Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This is an advance notice — the formal tender is expected to be published shortly. Interested parties can use this time to prepare documentation and identify potential partners.
Description
Auto-translated from fiREQUEST FOR INFORMATION: Filters for radiopharmaceutical production and drug manufacturing, as well as for pharmaceuticals and toxic alcohols With this request for information, HUS Group (hereinafter HUS) is initiating a market survey for a future procurement. The aim of this prior information notice is to find suppliers operating in the sector, to gather information on available solutions on the market, and to inform about the plans and requirements of the upcoming procurement.
This request for information concerns sterile filters for radiopharmaceutical production and drug manufacturing. The products in question (6 pcs), as well as the properties required from them, are described in the attachment to this request for information "Attachment 1 Products_filters for radiopharmaceutical production and drug manufacturing".
In addition, the request for information concerns ultrafiltration filters for two different uses. The filters are used to remove proteins before concentration determinations of toxic alcohol samples (S -Alko/ U -Alko, alcohol determinations from serum or urine; include sub-tests S-MeOH, S-EtOH, S-Ipro, S -Npro, S- Acetone, S-Etgly, S-Propgly, U -EtOH, U -MeOH, U-Ipro and U -Etgly) and free drug samples (S -Fenyt-V, S -Karba-V, S -Valpro-V) in serum.
Currently, HUS Diagnostic Center performs 1400 filtrations annually related to free drug determinations and 1600 filtrations related to toxic alcohol determinations (samples + controls + standards). Primarily, CE-marked filters suitable for IVD use will be procured if available on the market. For justified reasons, deviations from this may occur (e.g., poor performance of a product on the market, supply uncertainty, or other availability issues).
The products in question, as well as the properties required from them, are described in the attachment to this request for information "Attachment 2 Products_filters for pharmaceuticals and toxic alcohols". The attachment also includes clarifying questions for market participants regarding the products.
If you have products in your selection that match the description, we kindly ask you to respond to this request for information.
INSTRUCTIONS FOR RESPONDING TO THE REQUEST FOR INFORMATION
We ask you to review the attachments to this request for information and submit your responses by email to: kilpailutus.diagnostiikka@hus.fi
You may also attach brochures of products in your selection that fall within the scope of this request for information and meet the described requirements.
Responses must be submitted by 5.6.2026 at the latest. The subject line of the email or the message field must state: "REQUEST FOR INFORMATION: Filters for radiopharmaceutical production and drug manufacturing, as well as for pharmaceuticals and toxic alcohols".
In your response, please also clearly describe which of the products described above and in the attachment you may have in your selection (i.e., which product or products within the scope of the request for information your response concerns).
MARKET DIALOGUE
HUS may, at its discretion, propose further market dialogue discussions with those who have responded to this notice.
This notice is not a request for tender. Please note that the procurement is in the early stages of planning, and the plans and the subject of the procurement with its schedules may still change. This notice provides the information that the contracting entity has at the time of drafting the notice. The subject and schedule of the procurement may change substantially.
The request for information does not oblige the contracting entity to carry out the actual procurement; a decision to initiate a possible procurement procedure will be made separately. The request for information and the responses provided do not bind either party. Responding to the request for information will not affect the tenderer's position in a future tender competition.
The costs incurred by responding to the request for information remain the responsibility of the respondent, and HUS will not pay compensation for responding to the request for information or participating in the procurement procedure.
Lot 1: REQUEST FOR INFORMATION: Filters for radiopharmaceutical production and drug manufacturing, as well as for pharmaceuticals and toxic alcohols
With this request for information, HUS Group (hereinafter HUS) is initiating a market survey for a future procurement. The aim of this prior information notice is to find suppliers operating in the sector, to gather information on available solutions on the market, and to inform about the plans and requirements of the upcoming procurement.
This request for information concerns sterile filters for radiopharmaceutical production and drug manufacturing. The products in question (6 pcs), as well as the properties required from them, are described in the attachment to this request for information "Attachment 1 Products_filters for radiopharmaceutical production and drug manufacturing".
In addition, the request for information concerns ultrafiltration filters for two different uses. The filters are used to remove proteins before concentration determinations of toxic alcohol samples (S -Alko/ U -Alko, alcohol determinations from serum or urine; include sub-tests S-MeOH, S-EtOH, S-Ipro, S -Npro, S- Acetone, S-Etgly, S-Propgly, U -EtOH, U -MeOH, U-Ipro and U -Etgly) and free drug samples (S -Fenyt-V, S -Karba-V, S -Valpro-V) in serum.
Currently, HUS Diagnostic Center performs 1400 filtrations annually related to free drug determinations and 1600 filtrations related to toxic alcohol determinations (samples + controls + standards). Primarily, CE-marked filters suitable for IVD use will be procured if available on the market. For justified reasons, deviations from this may occur (e.g., poor performance of a product on the market, supply uncertainty, or other availability issues).
The products in question, as well as the properties required from them, are described in the attachment to this request for information "Attachment 2 Products_filters for pharmaceuticals and toxic alcohols". The attachment also includes clarifying questions for market participants regarding the products.
If you have products in your selection that match the description, we kindly ask you to respond to this request for information.
INSTRUCTIONS FOR RESPONDING TO THE REQUEST FOR INFORMATION
We ask you to review the attachments to this request for information and submit your responses by email to: kilpailutus.diagnostiikka@hus.fi
You may also attach brochures of products in your selection that fall within the scope of this request for information and meet the described requirements.
Responses must be submitted by 5.6.2026 at the latest. The subject line of the email or the message field must state: "REQUEST FOR INFORMATION: Filters for radiopharmaceutical production and drug manufacturing, as well as for pharmaceuticals and toxic alcohols".
In your response, please also clearly describe which of the products described above and in the attachment you may have in your selection (i.e., which product or products within the scope of the request for information your response concerns).
MARKET DIALOGUE
HUS may, at its discretion, propose further market dialogue discussions with those who have responded to this notice.
This notice is not a request for tender. Please note that the procurement is in the early stages of planning, and the plans and the subject of the procurement with its schedules may still change. This notice provides the information that the contracting entity has at the time of drafting the notice. The subject and schedule of the procurement may change substantially.
The request for information does not oblige the contracting entity to carry out the actual procurement; a decision to initiate a possible procurement procedure will be made separately. The request for information and the responses provided do not bind either party. Responding to the request for information will not affect the tenderer's position in a future tender competition.
The costs incurred by responding to the request for information remain the responsibility of the respondent, and HUS will not pay compensation for responding to the request for information or participating in the procurement procedure.
Data provenance
This notice is sourced from Hilma Finland and was originally published on May 27, 2026. Last refreshed 2 days ago. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About HUS-yhtymä
HUS-yhtymä has issued 313 procurement notices on BidsFactory, including 74 currently open and 128 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is November 27, 2026. You have 156 days left to prepare and submit your proposal to the contracting authority.
Who is the contracting authority?
This notice was issued by HUS-yhtymä in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.